Clinical Prognosis in Arrhythmia

In some people, arrhythmias are associated with heart diseases. In a very small number of people with serious symptoms, arrhythmia them-self is dangerous. These arrhythmias require medical treatment to keep the heartbeat regular. For example,  few people have  very slow heartbeat (bradycardia), causing them to feel lightheaded or faint. If left untreated, the heart can stop beating and these people could die and prognosis of Arrhythmia may includes duration of Arrhythmia, chances of complication of Arrhythmia, probable outcomes, prospects for recovery, recovery period for arrhythmia, survival rate, death rate, and other outcome possibilities in the overall prognosis of arrhythmia. Naturally, forecast issues are by their nature unpredictable. And various subtopics for clinical prognosis such as regenerative medicine prognosis in arrhythmia, atrial fibrillation and stem cell therapies. Stem-cell therapy is the therapy that uses stem cell for the treatment or prevention of disease or condition. Some come from bone marrow transplant which is most widely used.

Related Conference: Eighth Global Cardiologists Annual Meeting during July 18-20, 2016 Berlin, Germany; 11th  International Cardiac Conference September 14 -15, 2016 Philadelphia, USA; 8th International Conference on  Clinical and Experimental Cardiology November 14-16, 2016 San Francisco, USA; 7th World Cardio-thoracic Meeting December 5 - 6, 2016, Philadelphia, USA; 12th World Cardiology Congress during October 10–12, 2016 Manchester, UK; Symposium in Structural Heart disease Interventions  January 21-22, 2016 in Celebration, USA; International Stroke Conference February 17-19, 2016 Los Angeles, USA; Cardiology Issues in Younger Adults during September 15-24, 2016 Rome, Italy; World Conference in Cardiac Electrophysiology and Cardiac Techniques June 8-11, 2016 Nice, France; 65th Annual Scientific Session and Expo on Cardiology in American College April 02-04,2016 Chicago, USA.

For Arrhythmia prognosis vast majority of people with arrhythmias have nothing to fear. They do not need extensive exams or special treatments for their condition. In supraventricular tachycardia cardiac arrhythmia arising from improper electrical activity of the heart and it is a type of tachycardia(rapid heart rhythm) originating at or above the atrioventricular node. Stem cell therapy is very important therapy that is used where stem cells are treated to prevent the disease or any condition and some come also from bone marrow transplant.

  • Regenerative medicine prognosis in arrhythmia
  • Supraventricular tachycardia
  • Atrial fibrillation
  • Stem cell therapies

Related Conference of Clinical Prognosis in Arrhythmia

October 16-18, 2017

20th European Cardiology Conference

Hotel Mercure Budapest Buda, Budapest, Hungary
November 02-03, 2017

3rd Global Summit on Heart Diseases

Bangkok, Thailand
November 16-17, 2017

Annual Conference on Hypertension & Cardiac Nursing

Atlanta, USA
December 04-05, 2017

International Heart Conference

Dallas, Texas, USA
December 11-12, 2017

22nd World Cardiology Conference

Rome, Italy
February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

Dubai,UAE
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
June 18-19, 2018

EuroSciCon Conference on Bacteriology

Paris, France
June 25-26, 2018

Global Cardiology Summit

Kuala Lumpur, Malaysia
July 11-12, 2018

International Conference on Cardiovascular Imaging

Sydney,Australia
July 18-19, 2018

25th Annual Cardiology Conference

Atlanta, USA
September 10-12, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 26-27,2018

25th Annual Cardiologists Conference

Dubai,UAE

Clinical Prognosis in Arrhythmia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in